Companies › RXRX

RECURSION PHARMACEUTICALS IN (RXRX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001601830 · EDGAR filings · Updated 2026-07-27

RECURSION PHARMACEUTICALS IN (RXRX) has reported institutional ownership of 63.3%, with 334 institutional managers holding positions valued at $1.03B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-27 — Notice of proposed sale filed (Form 144)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Notice of proposed sale filed (Form 144)
• 2026-07-20 — Notice of proposed sale filed (Form 144)
• 2026-07-17 — Notice of proposed sale filed (Form 144)
• 2026-07-16 — Notice of proposed sale filed (Form 144)
• 2026-07-15 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, RECURSION PHARMACEUTICALS IN has 334 institutional holders and institutional ownership of 63.3%.

Insider activity

Insiders reported 98 transactions (0 buys, 27 sells) across 11 reporting insiders, with a net reported value of −$11.8M.

Related companies

AURINIA PHARMACEUTICALS INC (AUPH) · NOVOCURE LTD (NVCR) · IMMATICS N.V (IMTX) · CAPRICOR THERAPEUTICS INC (CAPR) · CORVUS PHARMACEUTICALS INC (CRVS) · XENCOR INC COM (XNCR)